CLGN Announces Termination of AbbVie Agreement, Launches Cost-Cutting Plan, Targets $100M Revenue by 2026
CollPlant Biotechnologies Ltd Ordinary Shares · Now $0.40
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS